Innovative Approaches to Drug Discovery and Development Chella, Naveen. editor. edt http://id.loc.gov/vocabulary/relators/edt Ranjan, Om Prakash. editor. edt http://id.loc.gov/vocabulary/relators/edt Alexander, Amit. editor. edt http://id.loc.gov/vocabulary/relators/edt SpringerLink (Online service) text si 2024 1st ed. 2024. monographic eng

electronic

electronic resource

access XIII, 248 p. 34 illus., 33 illus. in color. online resource. This book offers an insightful exploration of drug repurposing, an innovative approach to drug discovery and development that has the potential to revolutionize the field of medicine. It begins with an introduction to drug repurposing and its history, providing a comprehensive overview of the subject. The readers will embark on a journey through the diverse landscape of drug repurposing strategies. From in silico methods of predicting drug-disease associations to experimental approaches to the integrations of artificial intelligence (AI) and machine learning (ML) in drug repurposing for validating repurposed candidates. The book also delves into the application of drug repurposing in various disease areas, including cancer, inflammatory disorders, and CNS disorders. It explores the potential hurdles involved in the regulatory aspects of the process. The book further covers drug products under clinical trials and provides an overview of the future perspectives of drug repurposing. With its detailed and informative content, this book is a must-read for researchers, clinicians, and healthcare professionals interested in the exciting field of drug repurposing. Chapter 1. Drug repurposing: History, Significance, Benefits, Approaches and Challenges -- Chapter 2. Methodologies Adopted in Drug Repurposing -- Chapter 3. In silico methods used in drug repurposing -- Chapter 4. Role of artificial and machine learning in drug repurposing -- Chapter 5. Drug repurposing in cancer therapy -- Chapter 6. Drug repurposing in inflammatory disorders -- Chapter 7. Drug repurposing in CNS disorders -- Chapter 8. Reshaping the Therapeutic Landscape: Drug Repurposing for Emerging Infectious Diseases and Rare Diseases -- Chapter 9. Clinical trials on repurposed drugs: an overview -- Chapter 10. Intellectual Property Rights and Regulatory Considerations Throughout Drug Repurposing -- Chapter 11. Redirection to the Drug Discovery: Antidiabetic Drugs Repurposing in Cancer. edited by Naveen Chella, Om Prakash Ranjan, Amit Alexander. Drug delivery systems Pharmacovigilance Diseases Drug Delivery Drug Safety and Pharmacovigilance Diseases RS199.5 9789819750160 https://doi.org/10.1007/978-981-97-5016-0 https://doi.org/10.1007/978-981-97-5016-0 240829 20251030112919.0 978-981-97-5016-0